Article Information
History
- October 17, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jiaqi Liu1,2,3,#,
- Yalun Li4,#,
- Wanxiangfu Tang5,#,
- Lijun Dai2,#,
- Ziqi Jia3,#,
- Heng Cao3,
- Chenghao Li2,
- Yuchen Liu3,6,
- Yansong Huang3,6,
- Jiang Wu3,
- Dongxu Ma3,
- Guangdong Qiao4,
- Hua Bao5,
- Shuang Chang5,
- Dongqin Zhu5,
- Shanshan Yang5,
- Xuxiaochen Wu5,
- Xue Wu5,
- Hengyi Xu1,6,
- Hongyan Chen1,
- Yang Shao5,
- Xiang Wang3,*,
- Zhihua Liu1,* and
- Jianzhong Su2,*
- 1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
- 2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
- 3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
- 4Department of Breast Surgery, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China
- 5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
- 6School of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
- ↵*Corresponding authors. E-mail: sujz{at}wmu.edu.cn (Su J); liuzh{at}cicams.ac.cn (Liu Z); xiangw{at}vip.sina.com (Wang X).
↵# These authors contributed equally to this article.
Posted October 17, 2024.
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
